China's manufacturing activity contracted sharply in December for the third month in a row, according to Purchasing Managers' Index (PMI)
The coutry’s PMI came in at 47 points, down from November's 48 and well below the 50-point mark separating growth from contraction, despite China loosening COVID restrictions at the beginning of the month.
For over two years, China had imposed a zero-COVID strategy with strict quarantines, lockdowns, and mass testing that led to unannounced plant closures, disrupted supply chains, and forced permanent company closures.
China abruptly loosened pandemic restrictions on December 7, but the country is still struggling to recover due to a surge in COVID cases.
NBS senior statistician Zhao Qinghe noted that the pandemic has had a significant impact on business production and demand, staff presence, logistics, and distribution.
The index has not been in positive territory since September, and December's figure was lower than the 47.8 reading predicted by Bloomberg analysts.
For its part, the non-manufacturing PMI -- which includes the services and construction sectors -- also contracted further this month, to 41.6 points from 46.7 in November.


Texas App Store Age Verification Law Blocked by Federal Judge in First Amendment Ruling
Gold Price Breaks $4,500 as Safe-Haven Demand and Rate Cut Bets Fuel Rally
Tokyo Core Inflation Stays Above BOJ Target, Strengthening Case for Further Rate Hikes
China Revises 2024 GDP Lower After Final Review, Eyes Growth in 2025
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
U.S. Stock Index Futures Steady After S&P 500 Hits Record on Strong Economic Data
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
South Korea Central Bank Warns of Rising Financial Stability Risks Amid Won Volatility
Wall Street Ends Higher as S&P 500, Nasdaq Extend Gains Ahead of Holiday Week
FDA Names Tracy Beth Høeg as Acting CDER Director After Richard Pazdur Announces Retirement
Hyundai Recalls Over 51,000 Vehicles in the U.S. Due to Fire Risk From Trailer Wiring Issue
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Russian Stocks End Lower as Energy and Mining Shares Weigh on MOEX Index
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance 



